Product Browser
 
Product Compare
 
  • Click this icon to add products to compare list. Select up to 10 products.
  • Choose your location
Integrated Solutions & Services
BULK
100% Guarantee_July
ISO

POLE3 Pre-design Chimera RNAi   

  • Catalog # : H00054107-R01
  • Visit Frequency :
  • Current Country :
  • Size
  • Price
  • In Stock
  • Availability
  • Cart
  • 10 nmol
  • USD $ 239
  • Stock Image
  • order now, ship in 2 weeks
  • Add to Cart
  • 20 nmol
  • USD $ 289
  • Stock Image
  • order now, ship in 2 weeks
  • Add to Cart
  • Payment Information

    Credit card :
    or Purchase Order Number

  • Email : sales@abnova.com
    Phone : +1-909-992-0619 (new)
    Fax : +1-909-992-3401
  • Products will be shipped directly to the customer.
  • Product Compare
  • Save To Interest Product
  • Add Review
  • Print
  • PDF Download
  • Specification
  • Product Description:
  • Homo sapiens polymerase (DNA directed), epsilon 3 (p17 subunit) (POLE3), mRNA.
  • Reactivity:
  • Human
  • Supplied Product:
  • DEPC water
  • Target Refseq:
  • NM_017443
  • Storage Instruction:
  • Store at -20°C, do not exceed 4 - 5 freeze-thaw cycles to ensure product integrity.
  • Note:
  • Position of the Chimera RNAi.

  • Publication Reference
  • Applications
  • RNAi Knockdown
  • Application Image
  • RNAi Knockdown
  • Gene Information
  • Gene Name:
  • POLE3
  • Gene Alias:
  • CHARAC17,CHRAC17,YBL1,p17
  • Gene Description:
  • polymerase (DNA directed), epsilon 3 (p17 subunit)
  • Gene Summary:
  • POLE3 is a histone-fold protein that interacts with other histone-fold proteins to bind DNA in a sequence-independent manner. These histone-fold protein dimers combine within larger enzymatic complexes for DNA transcription, replication, and packaging.[supplied by OMIM
  • Other Designations:
  • DNA polymerase epsilon p17 subunit,DNA polymerase epsilon subunit 3,OTTHUMP00000021954,OTTHUMP00000021955,arsenic transactivated protein,chromatin accessibility complex 17,histone fold protein CHRAC17
    If you have a question or comment, please select the topic you would like to contact.

Your message has been sent successfully!